title: Current Challenges and Potential Opportunities for the Pharmaceutical Sciences to Make Global Impact: An FIP Perspective.
abstract: The chairs of each of the 8 Special Interest Groups of the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation have compiled opinions with regard to major challenges for the pharmaceutical sciences over the next 5-10 years. Areas covered are drug design and discovery, natural products, formulation design and pharmaceutical technology, pharmacokinetics/pharmacodynamics and systems pharmacology, translational and personalized medicine, biotechnology, analytical sciences and quality control, and regulatory science.
authors.affiliation: Department of Human Metabolism (Emeritus), Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK. Electronic address: g.t.tucker@sheffield.ac.uk.
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Tucker
authors.affiliation: Immunochemistry and Biomarker Development, Bristol-Myers Squibb, Lawrenceville, Princeton, New Jersey 08648.
authors.forename: Binodh
authors.initials: B
authors.lastname: DeSilva
authors.affiliation: Institute of Pharmaceutical Technology, Biocenter, Johann Wolfgang Goethe University, Frankfurt, Germany.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Dressman
authors.affiliation: Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
authors.forename: Michiho
authors.initials: M
authors.lastname: Ito
authors.affiliation: Department of Synthetic Organic Chemistry, Research Institute for Pharmaceutical Sciences, Musashino University, Nishitokyo, Tokyo, Japan.
authors.forename: Takuya
authors.initials: T
authors.lastname: Kumamoto
authors.affiliation: Department of Pharmaceutical Science, School of Pharmacy and Pharmaceutical Science, State University of New York at Buffalo, Buffalo, New York 14214.
authors.forename: Don
authors.initials: D
authors.lastname: Mager
authors.affiliation: Drug Product Services, Lonza AG, Basel, Switzerland.
authors.forename: Hanns-Christian
authors.initials: HC
authors.lastname: Mahler
authors.affiliation: Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
authors.forename: Anke H
authors.initials: AH
authors.lastname: Maitland-van der Zee
authors.affiliation: James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio 45219.
authors.forename: Giovanni M
authors.initials: GM
authors.lastname: Pauletti
authors.affiliation: Department of Hospital Pharmacy, Nagasaki University Hospital, Nagasaki, Japan.
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Sasaki
authors.affiliation: Pharmaceutical Consultant, North Potomac, Maryland 20878.
authors.forename: Vinod
authors.initials: V
authors.lastname: Shah
authors.affiliation: United-Power Pharma Tech, Beijing, China.
authors.forename: Daniel
authors.initials: D
authors.lastname: Tang
authors.affiliation: School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia 5000, Australia.
authors.forename: Michael
authors.initials: M
authors.lastname: Ward
mesh_terms: D001709:Biotechnology / Q000639:trends*; D016503:Drug Delivery Systems; D055808:Drug Discovery / Q000639:trends*; D038622:Internationality; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000737:chemistry / Q000592:standards; D010599:Pharmacokinetics; D012957:Societies, Pharmaceutical; D013678:Technology, Pharmaceutical / Q000639:trends*
chemical_list: D004364:Pharmaceutical Preparations
keywords: analytical chemistry; bioequivalence; biotechnology; drug design; materials science; natural products; pharmacodynamics; pharmacogenetics; pharmacokinetics